Updates on Grading and Staging of Prostate Cancer

Beth L. Braunhut, Sanoj Punnen, Oleksandr Kryvenko

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Since its development between 1966 and 1977, the Gleason grading system has remained one of the most important prognostic indicators in prostatic acinar adenocarcinoma. The grading system was first majorly revised in 2005 and again in 2014. With the publication of the 8th edition of the American Joint Committee on Cancer TNM staging manual in 2018, the classification of prostate cancer and its reporting have further evolved and are now included as part of staging criteria. This article reflects the aspects that are most influential on daily practice. A brief summary of 3 ancillary commercially available genomic tests is also provided.

Original languageEnglish (US)
Pages (from-to)759-774
Number of pages16
JournalSurgical Pathology Clinics
Volume11
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Neoplasm Staging
Prostatic Neoplasms
Neoplasm Grading
Publications
Adenocarcinoma

Keywords

  • Gleason grading system
  • Grade Groups
  • Prostate cancer
  • Staging

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine

Cite this

Updates on Grading and Staging of Prostate Cancer. / Braunhut, Beth L.; Punnen, Sanoj; Kryvenko, Oleksandr.

In: Surgical Pathology Clinics, Vol. 11, No. 4, 01.12.2018, p. 759-774.

Research output: Contribution to journalReview article

@article{26e351d74305409f864d56dbd98c78ca,
title = "Updates on Grading and Staging of Prostate Cancer",
abstract = "Since its development between 1966 and 1977, the Gleason grading system has remained one of the most important prognostic indicators in prostatic acinar adenocarcinoma. The grading system was first majorly revised in 2005 and again in 2014. With the publication of the 8th edition of the American Joint Committee on Cancer TNM staging manual in 2018, the classification of prostate cancer and its reporting have further evolved and are now included as part of staging criteria. This article reflects the aspects that are most influential on daily practice. A brief summary of 3 ancillary commercially available genomic tests is also provided.",
keywords = "Gleason grading system, Grade Groups, Prostate cancer, Staging",
author = "Braunhut, {Beth L.} and Sanoj Punnen and Oleksandr Kryvenko",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.path.2018.07.003",
language = "English (US)",
volume = "11",
pages = "759--774",
journal = "Surgical Pathology Clinics",
issn = "1875-9181",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Updates on Grading and Staging of Prostate Cancer

AU - Braunhut, Beth L.

AU - Punnen, Sanoj

AU - Kryvenko, Oleksandr

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Since its development between 1966 and 1977, the Gleason grading system has remained one of the most important prognostic indicators in prostatic acinar adenocarcinoma. The grading system was first majorly revised in 2005 and again in 2014. With the publication of the 8th edition of the American Joint Committee on Cancer TNM staging manual in 2018, the classification of prostate cancer and its reporting have further evolved and are now included as part of staging criteria. This article reflects the aspects that are most influential on daily practice. A brief summary of 3 ancillary commercially available genomic tests is also provided.

AB - Since its development between 1966 and 1977, the Gleason grading system has remained one of the most important prognostic indicators in prostatic acinar adenocarcinoma. The grading system was first majorly revised in 2005 and again in 2014. With the publication of the 8th edition of the American Joint Committee on Cancer TNM staging manual in 2018, the classification of prostate cancer and its reporting have further evolved and are now included as part of staging criteria. This article reflects the aspects that are most influential on daily practice. A brief summary of 3 ancillary commercially available genomic tests is also provided.

KW - Gleason grading system

KW - Grade Groups

KW - Prostate cancer

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=85056565159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056565159&partnerID=8YFLogxK

U2 - 10.1016/j.path.2018.07.003

DO - 10.1016/j.path.2018.07.003

M3 - Review article

C2 - 30447840

AN - SCOPUS:85056565159

VL - 11

SP - 759

EP - 774

JO - Surgical Pathology Clinics

JF - Surgical Pathology Clinics

SN - 1875-9181

IS - 4

ER -